Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta
about
Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasinReduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activationSyncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope geneSUMO-specific protease 2 is essential for modulating p53-Mdm2 in development of trophoblast stem cell niches and lineagesSuppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 proteinHepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cellsCrucial role for Mst1 and Mst2 kinases in early embryonic development of the mouseOtt1 (Rbm15) is essential for placental vascular branching morphogenesis and embryonic development of the heart and spleenThe ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.Membrane-anchored serine proteases in vertebrate cell and developmental biologyAcute disruption of bone marrow hematopoiesis by benzo(a)pyrene is selectively reversed by aryl hydrocarbon receptor-mediated processes.Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itineraryPurification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.Membrane-anchored serine proteases in health and disease.Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signalingLoss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.Hepatocyte growth factor activator (HGFA): molecular structure and interactions with HGFA inhibitor-1 (HAI-1).TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity.The basal chorionic trophoblast cell layer: An emerging coordinator of placenta development.Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19.Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation.Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin.Crystal Structure of a Two-domain Fragment of Hepatocyte Growth Factor Activator Inhibitor-1: FUNCTIONAL INTERACTIONS BETWEEN THE KUNITZ-TYPE INHIBITOR DOMAIN-1 AND THE NEIGHBORING POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN.Imbalance in the pro-hepatocyte growth factor activation system in bleomycin-induced lung fibrosis in mice.Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice.Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc.The cytotrophoblast layer of human chorionic villi becomes thinner but maintains its structural integrity during gestation.Down-regulation of HAI-1 is associated with poor-differentiation status of colorectal cancer.Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells.The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development
P2860
Q28267541-E486ABA8-677A-4D94-A718-8B8D32B297EBQ28483094-A2751850-02B0-4E52-BF58-2534D36D187EQ28507592-4667DFE7-805E-40E6-9E94-91FB793401FAQ28508647-A05EA09C-694A-479A-9549-9E469D1A5890Q28571434-ED1FC90A-B845-4A6E-971A-20118556F5EAQ28580138-C641A2C4-467F-4B6C-BC02-D0133A4AB082Q28586255-5FF95CBF-BD6B-488A-90CB-41C56ADD9968Q28588065-28AC6399-12E9-4CBC-AC4A-06A6DD4A0468Q33248805-6DD76B0A-4860-4124-A7A6-4FEA2C33DF6CQ33948580-9A106456-0D43-4861-8599-F3361512D9EEQ34715558-1212E4D8-3351-4646-9103-F050160EEA85Q35895533-4766765A-E516-44BC-B118-886A7E3445CBQ36753781-D6E9D47D-27F4-4DE5-B50F-0E3D400534EAQ36842289-97197115-BF81-44C3-AE3D-7EC43CC16858Q36944800-80C41E3B-48C2-49FF-BD92-81DD37E876D0Q36969010-09BB79CE-C9BC-4EB6-80DB-AA58223963E4Q37035839-BB583840-299F-48BF-AF44-13EA572DEE91Q37197314-FE018C33-2F9A-4CFB-ADB5-D0A257005FFFQ37733686-18111DBB-6328-4878-BF30-EE9F3ED1D693Q38339809-955779C2-22E8-424A-8B1C-E2B346332EA4Q38575459-8B874940-4EC5-4254-8E4C-20B55B284482Q38700458-6CA977A2-A48B-4869-ABF4-FE508CE90CEEQ38746986-033FF2F1-5AC9-4856-BF70-449A079599B9Q38859500-711A3E7F-AB25-4FD0-83F3-7AE2482E6F19Q38890925-09C85712-B61A-48F4-911E-2DBB6F357F2AQ39224627-A8A85323-81F5-4CF3-95F8-F5E4D722CDD4Q39409341-D02B5B00-8597-4E7F-B03B-A21FA5FEF7C1Q39478341-21EC88D6-B1EB-4EBC-AF1C-85BF5F654911Q39626361-F03F1E50-08E0-4A42-91C1-83777A5968A8Q39758360-23F5792E-9F34-4D43-AF24-A8D6F4830C1FQ39850267-8A2F36DC-AFB3-4032-9C1D-4AB62752C800Q39933011-13AC3092-C20A-49FC-BDC8-40D44233BB51Q40020532-000AF0DA-A825-4D3F-8742-64E9207A8E8EQ40284059-55785535-EF5C-49B5-996E-F2694030F4CEQ42502623-35E3E5DE-8B0D-4CE5-9F47-8B79D9B9EFCAQ44806334-999D0DA9-E413-4D18-98BC-1B7AB3CB6D0DQ46941051-DB7E774F-AA54-4835-8D8B-062FF2ED4728Q47171613-501B8BA0-64DE-421D-91B4-54D12E811872Q51764334-ED48BCEF-5DDA-466E-8B82-8E9F0CA9A7FDQ52573669-E281A64D-C6E8-4C4F-996E-14B1EB3571DD
P2860
Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta
description
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Juli 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/07/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/07/01)
@nl
наукова стаття, опублікована в липні 2005
@uk
مقالة علمية (نشرت في يوليو 2005)
@ar
name
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@ast
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@en
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@nl
type
label
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@ast
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@en
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@nl
prefLabel
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@ast
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@en
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@nl
P2093
P2860
P1476
Hepatocyte growth factor activ ...... n the chorioallantoic placenta
@en
P2093
Gen Yamada
Hiroaki Kataoka
Hiroshi Itoh
Hiroyuki Tanaka
Kazuyo Kohama
Koki Nagaike
Naoki Takeda
Naomi Kitamura
Shiro Miyata
Shuichiro Uchiyama
P2860
P304
P356
10.1128/MCB.25.13.5687-5698.2005
P407
P577
2005-07-01T00:00:00Z